Viewing nowHyuniz Glimepiride Tablets
Glimepiride 2mg
Tablet · Prescription medication
Huons Meditech Co., Ltd.

MFDS item code 201503191 · Approved 2015.05.27 · Insurance code 670400910
Improvement of glycemic control in type 2 diabetes mellitus
This medication is used to improve blood sugar control in patients with type 2 diabetes. It serves as an adjunct to dietary and exercise therapy, and can be administered as monotherapy. However, if blood sugar control is insufficient, it may be used in combination with oral hypoglycemic agents or insulin. Particularly, when control is difficult with sulfonylureas or metformin monotherapy, it may be co-administered with metformin to enhance blood sugar control. These various administration methods effectively assist patients in managing their blood sugar levels.
Adjust the dose individually for each patient. Swallow without chewing with at least 1/2 cup of water. Take this medicine orally once daily. It should be taken before breakfast or immediately before the first meal. It is very important not to skip a meal after taking this medicine. 1. Monotherapy 1) Initial dose and dose titration For patients who have not previously received drug therapy, start treatment with glimepiride 1 mg once daily. If necessary, increase the dose by 1 mg at intervals of 1 ~ 2 weeks. In general, doses above 4 mg provide little additional benefit, although some patients have achieved better metabolic control with doses increased to 6 mg (or 8 mg). If treatment with 4 mg daily is unsuccessful, first consider switching to insulin therapy; otherwise, consider combination therapy with insulin or another oral antidiabetic drug. 2) Subsequent dose adjustment As diabetes control improves during treatment, the requirement for this medicine may decrease. Therefore, dose reduction or discontinuation may be necessary to avoid hypoglycemia. Dose adjustment should also be considered if weight loss, lifestyle changes, or other factors that may increase the risk of hypoglycemia or hyperglycemia occur. 3) Switching from another oral blood glucose-lowering agent to this medicine There is no precise dose equivalence between this medicine and other oral blood glucose-lowering agents. When switching from another oral blood glucose-lowering agent, it is recommended to follow the instructions under Initial Dose. That is, start with 1 mg once daily and adjust the dose at intervals of 1 ~ 2 weeks. The potency and duration of action of the previous medicine should be taken into account. 4) Dose adjustment during treatment While taking this medicine, blood glucose and/or urine glucose levels should be measured regularly, and regular measurement of glycated hemoglobin (HbA1c) is also recommended. In general, hypoglycemia can be promptly controlled by taking sugar. Hypoglycemia may recur despite successful initial management during treatment with sulfonylureas. Therefore, patients should be carefully monitored. Severe hypoglycemia requires immediate medical treatment and follow-up, and hospitalization may sometimes be necessary. 2. Combination therapy 1) Combination therapy with insulin Combination therapy with this medicine and insulin is used in patients with secondary failure when fasting blood glucose (FBG) exceeds 150 mg/dL. Administer 8 mg of this medicine once daily with the first meal. Start insulin at a low dose and increase it approximately weekly according to fasting blood glucose measurements. Once stabilized, capillary blood glucose should be monitored daily whenever possible. The insulin dose should be adjusted periodically while monitoring blood glucose and glycated hemoglobin. 2) Combination therapy with metformin If the patient does not respond adequately to the maximum dose of this medicine, addition of metformin may be considered. Published clinical information is available on combination therapy of metformin with other sulfonylureas, such as glibenclamide, glipizide, chlorpropamide, and tolbutamide. When this medicine is used in combination with metformin, the desired blood glucose level may be achieved by adjusting the dose of each medicine. However, efforts should be made to determine the minimum effective dose of each medicine for blood glucose control. There is a risk of hypoglycemia with concomitant administration of this medicine and metformin, and the risk may be increased. Appropriate precautions should be taken.
This medication should not be used in patients with insulin-dependent diabetes, diabetic ketoacidosis, or in a comatose state. Additionally, it should not be administered to patients who have had hypersensitivity reactions to this medication or to sulfonylureas or sulfonamide medications. Experience with using this medication in patients with severe liver or kidney impairment is lacking, and in such cases, switching to insulin therapy is recommended. Women who are pregnant or may become pregnant and women who are breastfeeding should not take this medication. Patients with severe infections, undergoing surgery, or with major trauma should use insulin therapy, and in cases of gastrointestinal disorders like diarrhea or vomiting, absorption of the medication may decrease, increasing the risk of hypoglycemia. This medication contains lactose, so patients with lactose intolerance or certain inherited metabolic disorders should not take it. During the first week of dosing, the risk of hypoglycemia is high, so careful monitoring of blood sugar is especially necessary. High-risk patients for hypoglycemia include the elderly, those with poor nutritional status or irregular eating patterns, and those with excessive exercise and dietary imbalances. Additionally, patients who frequently consume alcohol or have impaired kidney and liver function, as well as those with endocrine disorders, require caution. Co-administration with other medications may influence blood sugar control, so patients should inform their doctor or pharmacist about any medications they are taking. This medication may cause hypoglycemia, with symptoms including headache, severe hunger, nausea, fatigue, anxiety, confusion, drowsiness, and loss of consciousness. Severe hypoglycemia may present with symptoms similar to a stroke, requiring immediate treatment. Some patients may experience visual disturbances, nausea, vomiting, abdominal pain, liver function abnormalities, blood-related reactions, and allergic reactions. If severe allergic reactions such as hives or difficulty breathing occur, medical attention should be sought immediately. This medication should be taken regularly, along with dietary and exercise measures, and it is important to maintain good blood sugar control. If hypoglycemia occurs, it can usually be promptly controlled by sugar intake, so patients should always carry sugar. During treatment, regular blood sugar and urine sugar level tests should be conducted, and treatment methods adjusted as needed. Additionally, caution is advised when driving or operating machinery due to impaired agility from hypoglycemia or hyperglycemia. This medication can interact with multiple drugs, so patients should inform healthcare personnel about other medications they are taking. In particular, changes in blood sugar may occur when taken with certain antibiotics, anticoagulants, steroids, or beta-blockers. Women who are pregnant or breastfeeding may pose risks to the fetus or neonate; therefore, insulin therapy is recommended instead of this medication. Children under 18 years of age should not use this medication as its safety and efficacy have not been established. Elderly patients may have reduced kidney function, so dosage adjustments should be made with caution. In cases of overdose, severe hypoglycemia may occur, requiring emergency measures such as inducing vomiting, gastric lavage, or intravenous glucose injection. This medication must be kept out of reach of children and stored in its original container to prevent misuse and deterioration of quality.
Hypoglycemia, headache, severe hunger, nausea, vomiting, fatigue, sleep, sleep disorders, anxiety, aggression, decreased concentration, decreased agility or initiative, depression, confusion, speech disorders, aphasia, visual disturbances, tremors, incomplete paralysis, perceptual disturbances, dizziness, weakness, loss of self-control, transient mental confusion, seizures, drowsiness, loss of consciousness, coma, shallow breathing, bradycardia, sweating, cold and clammy skin, tachycardia, hypertension, palpitations, angina, deep vein thrombosis, blurred vision, feelings of fullness or pressure in the upper abdomen, abdominal pain, diarrhea, increased liver enzymes, abnormal liver function, bile secretion disorders, jaundice, hepatitis, thrombocytopenia, leukopenia, hemolytic anemia, erythrocytopenia, granulocytopenia, agranulocytosis, pancytopenia, itching, urticaria, rash, respiratory distress, hypotension, shock, anaphylaxis, angioedema, Stevens-Johnson syndrome, allergic vasculitis, cutaneous photosensitivity reactions, decreased serum sodium concentration, taste disorders, hair loss, weight gain, dizziness, abnormal liver function, abdominal pain, joint pain, dyspepsia, facial swelling, erectile dysfunction, flushing, gastritis
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. The storage temperature should be kept between 1 to 30 degrees Celsius to maintain the effectiveness of the medication.
Green oval tablets
30 tablets/bottle, 200 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowGlimepiride 2mg
Tablet · Prescription medication
Huons Meditech Co., Ltd.

Glimepiride 1mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Handok Co., Ltd.

Glimepiride 4mg
Tablet · Prescription medication
(Hanmi Pharmaceutical Co., Ltd.)

Glimepiride 2mg
Tablet · Prescription medication
Seoul Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Shinpoong Pharmaceutical Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Glimepiride 2mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.